๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost-effectiveness of a predictive biomarker for bevacizumab responsiveness in the primary treatment of ovarian cancer

โœ Scribed by J. Barnett; A. Alvarez-Secord; D. Cohn; C. Leath; B. Peterson; E. Myers; L. Havrilesky


Book ID
113963712
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
133 KB
Volume
125
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES